Introduction
At the Central Serology Laboratory (CSL) Manchester, the treponemal haemagglutination (THA) test' has been carried out as part of the routine screening procedure for syphilis and positive reactions quantitated since mid-1969. At that time Price's precipitation reaction (PPR) was used as a quantitative test for reagin. It was noticed that most patients with untreated primary and secondary syphilis had higher titres with the PPR than with the THA test. Where the THA titre was higher than the PPR titre the diagnosis was usually treated syphilis or late or latent syphilis. When the Venereal Diseases Research Laboratory (VDRL) test was substituted for the PPR, and allowance was made for the higher sensitivity of the VDRL, this relationship remained.
During the later part of 1980 a computer program was developed using this observation, and further criteria were added on a trial and error basis until the program was highly selective for patients with untreated early syphilis. Each month since January 1981 computer printouts of all new cases of untreated syphilis other than late latent have been sent to the consultants in genitourinary medicine working in the north-west of England. Where available, the diagnosis used is that provided by the clinician. Also VDRL 
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The test was carried out with Wellcome antigen in WHO plates using double the volumes used in the slide test. Using a dropper 0-033 ml of antigen was added to 0 1 ml of serum in each well and the plates mechanically rotated for five minutes at about 120 rotations per minute. The tests were read with the naked eye on a light box with a tubular 60 watt filament bulb with its centre line 70 mm from the plate bottom. The inside of the box was matt black. The level of illumination was previously set to give the same sensitivity as when the slide test is read with a microscope at x 100, so that a weak positive reaction or quantitative endpbint is seen with the naked eye as a fine precipitate. This method does no detect "rough" negatives. specimens while a further 86 for whom no clinical diagnosis was given were diagnosed as early syphilis by the computer alone. The seven patients diagnosed as "other" were excluded on initial review of the material, three because of errors in coding, three from the misinterpretation of an unusual code by the program, and one from rediagnosis as untreated late latent syphilis.
The final diagnoses of patients attending departments of genitourinary medicine and the number of each group selected by the computer as untreated early syphilis are shown in table IV. Among the 43 patients diagnosed as untreated primary syphilis, the computer found 25. Among the 18 patients missed, five were seronegative, four had a positive or weakly reactive FTA-ABS test only, and in five the VDRL was positive and the FTA-ABS test weakly reactive or negative. Of the 55 patients with secondary syphilis, the computer found 37. Of the 18 missed, 15 were at a late stage with very high titres in the VDRL and THA tests. Another two of those missed were subsequently found to have been treated, and in one the specimen was too small for the VDRL test to be carried out. About half the patients with untreated early syphilis were selected by the computer because no clinical data were given on the request form. Inspection of the data showed that patients with untreated early syphilis not identified by the computer P J L Sequeira fell into two groups, those with early primary syphilis with little or no circulating antibody and those with late secondary syphilis with high titre test results. These data are consistent with the antibody pattern selected by the computer representing a phase in the normal development of the disease.
Our findings at the Central Serology Laboratory have shown that it is possible to diagnose 60%7o of patients with untreated early syphilis by the serological examination of one blood specimen and minimal other information. As the method is based on the VDRL titre being higher than that of the haemagglutination test associated with a positive FTA-ABS test, it follows that the VDRL or equivalent test must be included in the routine serological examination. In only five of the 43 patients diagnosed as having primary syphilis was the FTA-ABS test positive or weakly reactive and the VDRL negative. It would be unwise therefore to base the diagnosis of primary syphilis on the finding of an unconfirmed, unsupported reactive FTA-ABS test result. In most of these patients, however, the diagnosis was supported by positive dark field examination, which remains the method of choice, or by the VDRL also being positive on a confirmatory specimen, or by the clinical findings. Though during the period of this survey the routine use of the FTA-ABS test among contacts and other patients suspected of developing primary syphilis made little difference to the management of the cases, it was still of value as a confirmatory test. 
